Table 1.
Solvent | Microorganism | Culture | Antimicrobial Method | CUR Concentration |
Light/Ultrasonic Parameters | Reference |
---|---|---|---|---|---|---|
DMSO (0.4%) | ZIKV | Cell infection | IC50 | 5.62–16.57 µM | - | [19] |
>DGEV | >IC90 | |||||
N/R | HPVA | Cell infection | Viral survival | 0.015 mg/mL | - | [20] |
Tulane V | ||||||
N/R | KSPV | Infected cells | EC50 | Up to 6.68 µM | - | [21] |
Aqueous Piper nigrum seed extract | SARS-CoV-2 | Cell infection | IC50 Plaque reduction | 0.4 µg/mL | - | [22] |
DMSO (<0.4%) | SARS-CoV-1 | Cell infection | Inhibiton of viral replication | 20 µM | - | [23] |
N/R | SARS-CoV | In vitro | Viral inhibition | 23.5 µM | - | [24] |
N/R | SARS-CoV | In vitro | papain-like inhibition | 5.7 µM | - | [25] |
DMSO (1 w/v) | S. aureus | Planktonic | Inhibition zone MIC | 600 and | - | [26] |
E. coli | 400 µg/mL | |||||
DMSO | MRSA | Planktonic | MIC FICI |
15.5 µg/mL | - | [27] |
N/R | S. aureus | Planktonic | Colony count | 100 µg/mL | 8 or 20 J/cm2 | [28] |
MSSA | ||||||
MRSA | ||||||
DMSO (10%) | S. aureus | Biofilm | aPDT | 20, 40, and 80 µM | 5.28 J/cm2 | [29] |
DMSO | VRSA | Biofilm/animal infection model | MIC MBC |
156.25 µg/mL | 20 J/cm2 | [30] |
N/R | S. aureus | Animal infection model | aPDT | 78 µg/mL | 60 J/cm2 | [31] |
DMSO | S. aureus | Infected fruit | Survival fraction | 100 nM | 1.5 and 9 J/cm2 | [32] |
N/R | S. aureus | Planktonic | PDI | 40 and 80 µM | 15 J/cm2 | [33] |
E. coli | ||||||
Tween 80 (0.5%) | S. aureus | Planktonic | CFU/mL | 300 and 500 µM | 0.03–0.05 W/cm2 | [34] |
N/R | S. aureus | Biofilm | Confocal microscope | N/R | 170 µmol m2 s1 | [35] |
DMSO (0.5%) | S. aureus | Biofilm | SDT aPDT SPDT |
80 µM | 100 Hz 15 and 70 J/cm2 100 Hz, 15 and 70 J/cm2 |
[36] |
DMSO | E. coli | Planktonic | MIC Inhibition zone |
110, 220 and 330 µg/mL | - | [37] |
DMSO | E. coli | Planktonic | OD600nm | 8,16, 32, and 64 µg/mL | - | [38] |
N/R | S. dysenteriae | Planktonic | MIC/MBC | 256 and | - | [39] |
C. jejuni | 512 µg/mL | |||||
Edible alcohol | E. coli | Planktonic | aPDT | 5, 10, and 20 µM | 3.6 J/cm2 | [40] |
DMSO | H. pylori | Planktonic biofilm | MIC MBC aPDT |
50 µg/mL | 10 mW/cm2 | [41] |
DMSO | P. aeruginosa | Biofilm | aPDT CFU/mL |
N/R | 5 and 10 J/cm2 | [42] |
DMSO | Imipenem-resistant A. baumannii |
Planktonic | aPDT | 25, 50, 100, and 200 µM | 5.4 J/cm2 | [43] |
DMSO (2%) | P. aeruginosa, A. baumannii, K. pneumoniae, E. coli, E. faecalis | Planktonic | MIC/FICI | 128-256 µg/mL | - | [44] |
N/R | C. difficile, C. sticklandii, B. fragilis, P. bryantii | Planktonic | Viable cell number | 10 µg/mL | - | [45] |
N/R | B. subtillis, E. coli, S. carnosus, M. smegmatis | Planktonic | MIC/MBC | Up to 25 µM | - | [46] |
N/R | MRSA | Planktonic/animal infection model | MIC | 4–16 μg/mL | - | [47] |
MSSA | 2–8 μg/mL | |||||
E. coli | 8–32 μg/mL | |||||
N/R | E. faecalis, S. aureus, B. subtillis, P. aeruginosa, E. coli | Planktonic | MIC | 156 μg/mL | - | [48] |
DMSO (0.5%) |
A. hydrophila, E. coli E. faecalis, K. pneumoniae, P. aeruginosa, S. aureus, C. albicans |
Planktonic | MIC/MBC/ FICI/aPDT |
37.5–150 µg/mL | N/C | [49] |
N/R | E. faecalis | Infection model | CFU/mL | 1 µg/mL | - | [50] |
Commercial solution | E. faecalis | Biofilm | aPDT | 1.5 g/mL | 20.1 J/cm2 | [51] |
Ethanol 99% | A. hydrophila, V. parahaemolyticus | Planktonic | aPDT/SDT | Up to 15 mg/L | N/C | [52] |
DMSO (10%) | E. faecalis | Biofilm | MIC/MBC | 120 mg/mL | - | [53] |
N/R | S. mutans | Planktonic | aPDT | 10 g/100cc | N/C | [54] |
DMSO: ethyl alcohol | S. mutans, S. pyogenes | Planktonic | aPDT | 3 mg/mL | 28.8 J/cm2 | [55] |
DMSO (0.8%) | Caries isolated | Biofilm | aPDT | 600 µg/mL | 75 J/cm2 | [56] |
DMSO | S. mutans, C. albicans | Biofilm single/dual | MBEC | 0.5 mM | - | [57] |
DMSO (0.05 M) | A. actinomycetemcomitans | Planktonic | aPDT | 40 µg/mL | 300–420 J/cm2 | [58] |
DMSO (<1%) | P. gingivalis, A. actinomycetemcomitans | Planktonic | aPDT | 20 µg/mL | 6, 12 or 18 J/cm2 | [59] |
DMSO (0.5%) | P. gingivalis, A. actinomycetemcomitans, C. rectus, E. corrodens, F. nucleatum, P. intermedia, P. micra, T. denticola, T. forsythis | Biofilm | aPDT | 100 mg/L | - | [60] |
N/R | Subgingival plaque | Biofilm | aPDT | 100 µg/mL | 30 J/cm2 | [61] |
DMSO | P. gingivalis | Planktonic | MIC | 12.5 µg/mL | - | [62] |
Ethanol: DMSO (99.9%: 0.1%) |
Periodontal pocket | - | aPDT | 100 mg/mL | 7.69 J/cm2 | [63] |
Tween 80 | Streptococcus spp, Staphylococcus spp, Enterobacteriaceae, C. albicans | Clinical trail | aPDT | 0.75 mg/mL | 20.1 J/cm2 | [64] |
Sodium hydroxide: PBS | C. albicans, C. parapsilosis, C. glabrata, C.dubliniensis | Planktonic/biofilm | MIC | 0.1–0.5 mg/mL | - | [65] |
N/R | C. albicans, S. aureus | Planktonic Biofilm |
MIC/Biofilm percentag | 200 µg/mL | - | [66] |
N/R | C. albicans | Biofilm | aPDT | 1.5 g/mL | 20.1 J/cm2 | [67] |
DMSO (10%) | C. albicans | Biofilm | aPDT | 20, 40, 60 and 80 µM | 2.64, 5.28, 7.92, 10.56, and 13.2 J/cm2 | [68] |
DMSO (1%) | C. albicans | Biofilm | aPDT | 40 and 80 mM | 37.5 and 50 J/cm2 | [69] |
N/R | C. albicans | Biofilm | aPDT | 100 µM | 10 J/cm2 | [70] |
DMSO (2.5%) | Fluconazole-resistant C. albicans | Planktonic/biofilm/infection model | MIC/ aPDT |
40 µM | 5.28 J/cm2 | [71] |
Fluconazole-susceptible C. albicans | 80 µM | 40.3 J/cm2 | ||||
DMSO | C. albicans, F. oxysporum, A. flavus, A. niger, C. neoformans | Planktonic | MIC | 137.5–200 μg/mL | - | [72] |
-: not performed. N/R: not reported. N/C: not clear.